@article{3002760,
    title = "Risks in surrogacy considering the embryo: From the preimplantation to the gestational and neonatal period",
    author = "Simopoulou, M. and Sfakianoudis, K. and Tsioulou, P. and Rapani, A. and Anifandis, G. and Pantou, A. and Bolaris, S. and Bakas, P. and Deligeoroglou, E. and Pantos, K. and Koutsilieris, M.",
    journal = "BioMed Research International",
    year = "2018",
    volume = "2018",
    publisher = "Hindawi Limited",
    issn = "2314-6133, 2314-6141",
    doi = "10.1155/2018/6287507",
    keywords = "controlled study;  embryo;  fetus;  human;  infant;  male;  newborn period;  ovulation induction;  preimplantation embryo;  review;  single (marital status);  sperm donor;  birth;  female;  infertility;  pregnancy;  prenatal care;  risk;  surrogate mother, Female;  Humans;  Infant;  Infertility;  Parturition;  Pregnancy;  Prenatal Care;  Risk;  Surrogate Mothers",
    abstract = "Surrogacy is an assisted reproduction-based approach in which the intended parents assign the gestation and birth to another woman called the surrogate mother. The drivers of surrogacy refer largely to infertility, medical conditions, same-sex couples' parenting, and cases of diversity regarding sexual identity and orientation. Surrogacy consists of a valid option for a variety of conditions or circumstances ranging from medical to social reasons. However, surrogacy may be associated with risks during the preimplantation, prenatal, and neonatal period. It became obvious during the exhaustive literature research that data on surrogacy and its association with factors specific to the IVF practice and the options available were not fully represented. Could it be that surrogacy management adds another level of complexity to the process from the ovarian stimulation, the subsequent IVF cycle, and the techniques employed within the IVF and the Genetic Laboratory to the fetal, perinatal, and neonatal period? This work emphasizes the risks associated with surrogacy with respect to the preimplantation embryo, the fetus, and the infant. Moreover, it further calls for larger studies reporting on surrogacy and comparing the surrogate management to that of the routine IVF patient in order to avoid suboptimal management of a surrogate cycle. This is of particular importance in light of the fact that the surrogate cycle may include not only the surrogate but also the egg donor, sperm donor, and the commissioning couple or single person. © 2018 M. Simopoulou et al."
}